Insider trading

Period: 12 months + Add filter
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,110 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,110 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,110 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,110 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,110 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,110 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,110 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
5 Oct 2026
Muken Ross Chief Executive Officer
Sold on a plan
$79.97K 9,838 at 8.13
1.5%
Planned (10b5-1)
5 Oct 2026
Prahm Jeremy Chief Investment Officer
Sold on a plan
$79.20K 6,000 at 13.20
3.7%
Planned (10b5-1)
5 Oct 2026
Horan Christopher Chief Tech Operations Officer
Sold at will
$70.70K 10,340 at 6.84
3.2%
Not planned
5 Oct 2026
Leaver Andrew Chief Executive Officer
Sold at will
$60.29K 2,535 at 23.78
4.3%
Not planned
5 Oct 2026
Menu Philippe Chief Medical Officer
Sold on a plan
$60.10K 7,394 at 8.13
3.5%
Planned (10b5-1)
5 Oct 2026
Xu Zhenyu Chief Scientific Officer
Sold on a plan
$60.07K 7,394 at 8.12
1.3%
Planned (10b5-1)
5 Oct 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan
$59.70K 82 at 728.08
1.4%
Planned (10b5-1)
5 Oct 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan
$59.70K 82 at 728.08
1.4%
Planned (10b5-1)
5 Oct 2026
Bush Jennifer COO, CLO, Compliance Officer
Sold at will
$57.23K 8,370 at 6.84
2.2%
Not planned
5 Oct 2026
Sold at will
$55.34K 4,161 at 13.30
10.6%
Not planned
5 Oct 2026
Knotnerus Tim Jasper Chief Executive Officer
Bought
$50.88K 6,000 at 8.48
55.4%
Cluster · 3 buyers
5 Oct 2026
Van Well Daan Chief Legal Officer
Sold on a plan
$50.10K 6,168 at 8.12
1.8%
Planned (10b5-1)
5 Oct 2026
Gyftakis Stavros See Remarks
Sold at will
$49.67K 2,835 at 17.52
1.2%
Not planned
5 Oct 2026
Tabak Shawn CHIEF FINANCIAL OFFICER
Sold at will
$46.22K 2,746 at 16.83
1.3%
Not planned
5 Oct 2026
WANG YUFAN STEPHANIE Chief Legal Officer
Sold on a plan
$46.07K 1,245 at 37.00
26.3%
Planned (10b5-1)
5 Oct 2026
Lawrence Philippa Chief Accounting Officer
Sold on a plan
$45.33K 3,492 at 12.98
0.9%
Planned (10b5-1)
5 Oct 2026
Bought
$43.78K 11,750 at 3.73
1.6%
5 Oct 2026
Verma Abhimanyu Chief Technology Officer
Sold on a plan
$42.93K 5,284 at 8.12
3.1%
Planned (10b5-1)
5 Oct 2026
Epstein David R Director
Bought
$42.85K 5,000 at 8.57
opened
Cluster · 3 buyers
5 Oct 2026
Reske James R EVP/Chief Financial Officer
Sold on a plan 6×
$42.51K 2,072 at 20.52
2.8%
Planned (10b5-1)
5 Oct 2026
CHANG FRED FACHING Director · indirect
Sold at will
$42.33K 3,582 at 11.82
0.1%
Not planned
5 Oct 2026
Olivan Javier Chief Operating Officer · indirect
Sold on a plan
$41.50K 57 at 728.08
5.1%
Planned (10b5-1)
5 Oct 2026
Jolley David R Director
Sold at will
$41.06K 12,845 at 3.20
4.6%
Not planned
5 Oct 2026
Zhao Bin Chief Executive Officer · indirect
Bought on a plan
$40.56K 9,713 at 4.18
0.5%
Bought on a plan
5 Oct 2026
Mulacek Phil E Director · indirect
Bought
$38.77K 14,508 at 2.67
1.6%
5 Oct 2026
Reynoso Jamie L. CEO, Medicare Advantage
Sold on a plan
$38.68K 8,750 at 4.42
0.3%
Planned (10b5-1)
5 Oct 2026
Coen Steven P. See remarks
Sold at will
$36.05K 2,403 at 15.00
4.6%
Not planned
5 Oct 2026
SIEGEL IAN H. CHIEF EXECUTIVE OFFICER
Sold on a plan
$34.92K 9,722 at 3.59
5.4%
Planned (10b5-1)
5 Oct 2026
Gur Osnat Director
Bought
$34.84K 7,500 at 4.65
opened
First buy on file
5 Oct 2026
Valente Manuela Chief People Officer
Sold on a plan
$34.49K 4,240 at 8.13
2.0%
Planned (10b5-1)
5 Oct 2026
Maheshwari Anshul Chief Op & Financial Officer
Sold on a plan
$33.75K 1,731 at 19.50
0.8%
Planned (10b5-1)
5 Oct 2026
Herb Tyler Chief Accounting Officer
Sold on a plan
$30.66K 1,418 at 21.63
0.6%
Planned (10b5-1)
5 Oct 2026
Bowles Gregory Chief Policy Officer
Sold on a plan
$30.65K 5,302 at 5.78
2.7%
Planned (10b5-1)
5 Oct 2026
LARSON KEITH R Director
Sold on a plan
$26.62K 250 at 106.48
1.7%
Planned (10b5-1)
5 Oct 2026
Ghamsari Nima HEAD OF BLEND
Sold on a plan
$24.66K 24,272 at 1.02
0.3%
Planned (10b5-1)
5 Oct 2026
ADAR1 Capital Management, LLC 10% owner · indirect
Bought
$24.18K 18,182 at 1.33
2.0%
5 Oct 2026
Narayanadas Vivek General Counsel & Secretary
Sold at will
$23.32K 649 at 35.93
6.9%
Not planned
5 Oct 2026
Rajaram Gokul Director
Sold on a plan
$21.00K 1,050 at 20.00
2.8%
Planned (10b5-1)
5 Oct 2026
Clark Anthony S. Director
Bought
$19.45K 2,000 at 9.73
33.3%
+33% of stake
5 Oct 2026
Saba Capital Management, L.P. 10% owner · indirect
Bought
$16.65K 1,775 at 9.38
0.1%
5 Oct 2026
Willcocks Patrick General Counsel
Sold at will
$13.99K 588 at 23.78
4.8%
Not planned
5 Oct 2026
Gyftakis Stavros See Remarks
Sold at will
$13.45K 5,000 at 2.69
2.0%
Not planned
5 Oct 2026
CARDOZA GEORGE Chief Financial Officer
Sold on a plan
$12.90K 1,592 at 8.10
0.5%
Planned (10b5-1)
5 Oct 2026
Feenan Paul Chief Revenue Officer
Sold at will
$12.68K 533 at 23.78
2.4%
Not planned
5 Oct 2026
Nilan Nicholas William General Manager-US
Sold at will
$12.42K 522 at 23.78
36.6%
Not planned
5 Oct 2026
Dai Kun Chief Executive Officer · indirect
Bought on a plan
$11.02K 8,683 at 1.27
28.4%
Bought on a plan
5 Oct 2026
Bertolini Jeffrey Chief Operating Officer
Sold on a plan
$10.75K 747 at 14.39
3.2%
Planned (10b5-1)
5 Oct 2026
Eberwein Jeffrey E. Chief Executive Officer
Sold on a plan
$9.21K 1,000 at 9.21
0.1%
Planned (10b5-1)
5 Oct 2026
Banerjee Subhashis Chief Medical Officer
Sold at will
$7.51K 1,099 at 6.84
0.6%
Not planned
5 Oct 2026
Lee Kevin CHIEF EXECUTIVE OFFICER
Sold at will
$5.85K 1,638 at 3.57
0.3%
Not planned
Showing 651–700 of 60,110. ← Newer Page 14 of 1,203 Older →